Five Prime Therapeutics, Inc. financial reports, Five Prime Therapeutics, Inc. annual revenue in 2024. When does Five Prime Therapeutics, Inc. report revenue?
Five Prime Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
The dynamics of Five Prime Therapeutics, Inc. net revenue has changed by -349 000 $ over the last period. The dynamics of Five Prime Therapeutics, Inc. net income fell by -1 678 000 $ for the last reporting period. Here are the main financial indicators of Five Prime Therapeutics, Inc.. The financial schedule of Five Prime Therapeutics, Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. Five Prime Therapeutics, Inc. financial report on the graph shows the dynamics of assets. The value of Five Prime Therapeutics, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
2 984 000 $
-48.293 % ↓
-36 069 000 $
-
30/06/2019
3 333 000 $
-56.029 % ↓
-34 391 000 $
-
31/03/2019
5 347 000 $
-83.541 % ↓
-35 385 000 $
-
31/12/2018
4 031 000 $
-69.504 % ↓
-38 753 000 $
-
30/09/2018
5 771 000 $
-
-47 244 000 $
-
30/06/2018
7 580 000 $
-
-34 060 000 $
-
31/03/2018
32 486 000 $
-
-20 390 000 $
-
31/12/2017
13 218 000 $
-
-29 211 000 $
-
30/09/2017
8 333 000 $
-
-43 282 000 $
-
30/06/2017
7 822 000 $
-
-44 286 000 $
-
Show:
to
Five Prime Therapeutics, Inc. financial report charts
Dates of Five Prime Therapeutics, Inc. finance reports: 30/06/2017, 30/06/2019, 30/09/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Five Prime Therapeutics, Inc. for today is 30/09/2019. Gross profit Five Prime Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Five Prime Therapeutics, Inc. is -23 964 000 $
Five Prime Therapeutics, Inc. quarterly report dates
Cost of revenue Five Prime Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Five Prime Therapeutics, Inc. is 26 948 000 $ Total revenue Five Prime Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Five Prime Therapeutics, Inc. is 2 984 000 $ Operating revenue Five Prime Therapeutics, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Five Prime Therapeutics, Inc. is 2 984 000 $
Operating income Five Prime Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Five Prime Therapeutics, Inc. is -37 170 000 $ Net income Five Prime Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Five Prime Therapeutics, Inc. is -36 069 000 $ Current assets Five Prime Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Five Prime Therapeutics, Inc. is 197 492 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-23 964 000 $
-26 092 000 $
-24 606 000 $
-30 702 000 $
-38 916 000 $
-25 800 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
26 948 000 $
29 425 000 $
29 953 000 $
34 733 000 $
44 687 000 $
33 380 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 984 000 $
3 333 000 $
5 347 000 $
4 031 000 $
5 771 000 $
7 580 000 $
32 486 000 $
13 218 000 $
8 333 000 $
7 822 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
2 984 000 $
3 333 000 $
5 347 000 $
4 031 000 $
5 771 000 $
7 580 000 $
32 486 000 $
13 218 000 $
8 333 000 $
7 822 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-37 170 000 $
-35 753 000 $
-35 116 000 $
-40 281 000 $
-48 748 000 $
-35 582 000 $
-21 544 000 $
-29 932 000 $
-44 074 000 $
-43 285 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-36 069 000 $
-34 391 000 $
-35 385 000 $
-38 753 000 $
-47 244 000 $
-34 060 000 $
-20 390 000 $
-29 211 000 $
-43 282 000 $
-44 286 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
43 552 000 $
32 671 000 $
42 733 000 $
41 744 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
40 154 000 $
39 086 000 $
40 463 000 $
44 312 000 $
54 519 000 $
43 162 000 $
54 030 000 $
43 150 000 $
52 407 000 $
51 107 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
197 492 000 $
230 015 000 $
250 541 000 $
288 568 000 $
332 857 000 $
363 021 000 $
403 043 000 $
311 190 000 $
333 354 000 $
363 304 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
258 540 000 $
292 911 000 $
315 764 000 $
321 534 000 $
366 364 000 $
396 778 000 $
436 714 000 $
344 047 000 $
357 417 000 $
380 111 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
48 933 000 $
38 306 000 $
29 632 000 $
43 953 000 $
64 045 000 $
52 785 000 $
67 484 000 $
59 790 000 $
36 448 000 $
59 709 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
28 509 000 $
33 502 000 $
24 072 000 $
27 487 000 $
39 519 000 $
30 223 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
389 426 000 $
292 690 000 $
320 758 000 $
350 718 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
80 106 000 $
86 299 000 $
81 438 000 $
56 395 000 $
69 586 000 $
59 920 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
30.98 %
29.46 %
25.79 %
17.54 %
18.99 %
15.10 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
178 434 000 $
206 612 000 $
234 326 000 $
265 139 000 $
296 778 000 $
336 858 000 $
362 216 000 $
265 202 000 $
286 089 000 $
323 274 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-27 917 000 $
-23 654 000 $
-32 676 000 $
-52 578 000 $
-30 933 000 $
-28 381 000 $
-10 622 000 $
-27 463 000 $
-27 704 000 $
-29 088 000 $
Last revenue report of Five Prime Therapeutics, Inc. was 30/09/2019. According to last financial report total revenue in Five Prime Therapeutics, Inc. was 2 984 000 US dollar and changed by -48.293% since last year. Net income in Five Prime Therapeutics, Inc. was -36 069 000 $ in last quartal, net income changes to 0%.
Total assets Five Prime Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Five Prime Therapeutics, Inc. is 258 540 000 $ Current cash Five Prime Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Five Prime Therapeutics, Inc. is 48 933 000 $ Current debt Five Prime Therapeutics, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Five Prime Therapeutics, Inc. is 28 509 000 $
Five Prime Therapeutics, Inc. stocks data
FPRX stock price
Five Prime Therapeutics, Inc. stock price today, FPRX stock quote.
